Olaf Eickmeier
3PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 13, 2026
Relating Improvement in Gastrointestinal (CFAbd-Score©) and Sinonasal (SNOT) Symptoms During Therapy With Elexacaftor/Tezacaftor/Ivacaftor in CF Patients.Jochen G Mainz, Vivien Greiner, Pauline Sadrieh
|Dec 31, 2019
Clinical relevance of Aspergillus fumigatus sensitization in cystic fibrosis.Olaf Eickmeier, Ulrich M Zissler, Julia Wittschorek
|Feb 04, 2017
Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.Olaf Eickmeier, Daniela Fussbroich, Klaus Mueller
Pageof 1
